- Founded
- 2019
- Employees
- 75
- Total Funding
- $60.1M
Founded by Emmanuelle Rolland-Martiano, Maximilien Levesque in 2019.
About AQEMIA
AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge science with advanced technology. Powered by physics-based modeling, statistical mechanics, and generative AI, QEMI allows our teams to design novel drug candidates from first principles. What makes AQEMIA different is our commitment to true innovation: our research is dedicated to the invention of new molecular entities, not the refinement of existing ones.
Leadership at AQEMIA
The team at the top of the org chart.
Maximilien Levesque
CEO & co-founder
36 reports
Ingrid Delval
Chief of Staff
Orianne Bornand
Head of Communications and Marketing
Théa Vu - Bignand
Head of Finance
1 report
Emmanuelle Martiano Rolland
Co-Founder & COO
5 reports
Sylvain Sabi
VP Engineering
13 reports
Dr Veronique Birault Fmedsci
VP Translational Sciences
3 reports
Nicolas Canouï
VP of Drug Discovery Platform
3 reports
Olivier Bezençon
VP Medicinal Chemistry
3 reports
Open Jobs at AQEMIA (3)
Similar companies hiring
Top employers in Artificial Intelligence (AI)